Iron deficiency without anemia is a common feature of moderate-to-severe atopic dermatitis (AD), according to a study ...

In fully adjusted models, kids with atopic dermatitis had a 44% increased risk of IBD (HR 1.44, 95% CI 1.31-1.58), while adults had a 34% increased risk (HR 1.34, 95% CI 1.27-1.40) compared with ...

This article was originally published by Dermatology Times. An open-label extension study (NCT01949311) has demonstrated acceptable safety of dupilumab (Dupixent) in treating adult patients with ...

LAPIX Therapeutics, Inc. (“LAPIX”), a clinical-stage biopharmaceutical company developing first-in-class, orally delivered immune-tolerance-restoring therapies, announced today that the first patient ...

The Adbry autoinjector is for use in adults only. A new single-dose autoinjector presentation of Adbry ® (tralokinumab-ldrm) is now available for use in the treatment of moderate to severe atopic ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

Findings showed 16.4% of patients treated with rocatinlimab achieved rIGA success compared with 4.9% of patients who received placebo. Topline results were announced from a phase 3 trial evaluating ...

Please provide your email address to receive an email when new articles are posted on . Zoryve (roflumilast) cream 0.15% is approved for the treatment of mild to moderate atopic dermatitis. The ...

Results of a trial show that tralokinumab is safe, tolerable and effective in older adults to treat moderate to severe atopic dermatitis. The drug is already approved for adults who have the condition ...

Experts discuss the unique challenges of managing atopic dermatitis (AD) in pediatric and adolescent patients, emphasizing the strategic use of topical treatments to improve adherence, reduce ...

Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...

The American Academy of Dermatology (AAD) periodically issues clinical guidelines for the management of atopic dermatitis (AD) that include specific evidence-based recommendations formulated by a ...